On 19 September 2022, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have published a joint statement confirming that biosimilars authorized in the EU are ...
BELLEVUE, Wash.--(BUSINESS WIRE)--Healthcare Management Administrators (HMA), a pioneer in self-funded health benefit programs and one of the nation’s largest third-party administrators, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results